Invention Grant
- Patent Title: 1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins
-
Application No.: US15774868Application Date: 2016-11-08
-
Publication No.: US10730902B2Publication Date: 2020-08-04
- Inventor: Fredrik Zetterberg , Ulf Nilsson , Hakon Leffler , Anders Pedersen , Hans Schambye , Thomas Brimert , Richard Johnsson
- Applicant: GALECTO BIOTECH AB
- Applicant Address: DK Copenhagen
- Assignee: GALECTO BIOTECH AB
- Current Assignee: GALECTO BIOTECH AB
- Current Assignee Address: DK Copenhagen
- Agency: Maier & Maier, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@45c341e2 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7081380c
- International Application: PCT/EP2016/076918 WO 20161108
- International Announcement: WO2017/080973 WO 20170518
- Main IPC: C07H19/056
- IPC: C07H19/056 ; A61P27/02
Abstract:
The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
Public/Granted literature
- US20180327440A1 NOVEL GALACTOSIDE INHIBITORS OF GALECTINS Public/Granted day:2018-11-15
Information query
IPC分类:
